TickerGuard
Buy Day today: Good (62) Broad market participation · no major macro event
INO

Inovio Pharmaceuticals Inc

Healthcare · Biotechnology

1.20$ +5.2% vs. previous close Closing price · As of: Sep 17, 2026

Filings

Filings

Listed US companies must report material events to the Securities and Exchange Commission. This page lists the filings of Inovio Pharmaceuticals Inc (INO) with date, type and a link to the original document.

Filings INO
Date Type Filing Original
07/30/2026 Capital measure Form 424B5 filed with the SEC View document ↗
07/29/2026 Capital measure Form 424B5 filed with the SEC View document ↗

Showing the 100 most recent filings of the selected type.

Data as of: September 17, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q) · Filings: SEC EDGAR

Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.

Was this page helpful to you?